MetaADEDB 2.0 @ LMMD
Kovanaze
(VRNWVNYWQWKKCB-UHFFFAOYSA-N)
Structure
SMILES
Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C.CCCCNc1ccc(cc1)C(=O)OCCN(C)C.Cl.Cl
Molecular Formula:
C31H50Cl2N4O3
Molecular Weight:
597.660
Log P:
6.9091
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
5
TPSA:
86.19
CAS Number(s):
N/A
Synonym(s)
1.
Kovanaze
External Link(s)
PubChem Compound59054565
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 9US FAERS
2Nasal discomfortFAERS: 9US FAERS
3Intentional product misuseFAERS: 7US FAERS
4EpistaxisFAERS: 6US FAERS
5HeadacheFAERS: 5US FAERS
6Application site painFAERS: 2US FAERS
7Burning sensationFAERS: 2US FAERS
8NasopharyngitisFAERS: 2US FAERS
9Oropharyngeal painFAERS: 2US FAERS
10RhinalgiaFAERS: 2US FAERS
11Sinus headacheFAERS: 2US FAERS
12SneezingFAERS: 2US FAERS
13Throat irritationFAERS: 2US FAERS
14Abdominal discomfortFAERS: 1US FAERS
15Drug effect incompleteFAERS: 1US FAERS
16Ear congestionFAERS: 1US FAERS
17Expired product administeredFAERS: 1US FAERS
18Eye inflammationFAERS: 1US FAERS
19Eye irritationFAERS: 1US FAERS
20Eye painFAERS: 1US FAERS
21Facial PainFAERS: 1US FAERS
22Feeling abnormalFAERS: 1US FAERS
23HypersensitivityFAERS: 1US FAERS
24Instillation site irritationFAERS: 1US FAERS
25Nasal mucosal disorderFAERS: 1US FAERS
26NauseaFAERS: 1US FAERS
27OverdoseFAERS: 1US FAERS
28PainFAERS: 1US FAERS
29Product storage errorFAERS: 1US FAERS
30Productive CoughFAERS: 1US FAERS
31Urinary RetentionFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.